Study groups were matched by age, duration of diabetes, sex, BMI and HbA1c at baseline. HbA1c declined at 1 year by 0.68 percentage points in the tirzepatide group and 0.54 percentage points in ...

Average age was 54.3 years and 63.7% were male. At baseline, HbA1c was 8.2%, body mass index (BMI) was 25.5, and fasting plasma glucose was 160.7 mg/dL. Prior to the study, all participants ...

glycosolated hemoglobin [HbA1c] levels, body mass index [BMI], and insulin utilization) were related to the rate of progression of retinopathy. Main Outcome Measures: Correlation between lifestyle ...

This study shows that in an outpatient population undergoing screening in a health care setting, HbA1c strongly predicts the development of diabetes. Obese patients were more likely to develop ...

The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...

A phase II clinical trial in China has found that berberine ursodeoxycholate (HTD1801) effectively improved HbA1c levels in ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.